Arcutis Biotherapeutics
ARQT
ARQT
139 hedge funds and large institutions have $1.06B invested in Arcutis Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 19 reducing their positions, and 11 closing their positions.
Holders
139
Holders Change
+24
Holders Change %
+20.87%
% of All Funds
2.4%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
35
Increased
68
Reduced
19
Closed
11
Calls
$5.86M
Puts
$349K
Net Calls
+$5.51M
Net Calls Change
+$1.91M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
CFGS
152
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
153
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
EI
154
Ellevest Inc
New York
| $0 | 2 | +2 | New |
|